Get the Stockscreener App
0.965
3.16%
-0.0315
Cardiol Therapeutics Inc stock is traded at $0.965, with a volume of 499.34K.
It is down -3.16% in the last 24 hours and down -8.10% over the past month.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
See More
Previous Close:
$0.9965
Open:
$1.02
24h Volume:
499.34K
Relative Volume:
0.72
Market Cap:
$82.94M
Revenue:
-
Net Income/Loss:
$-21.65M
P/E Ratio:
-2.9058
EPS:
-0.3321
Net Cash Flow:
$-15.84M
1W Performance:
-5.39%
1M Performance:
-8.10%
6M Performance:
-13.84%
1Y Performance:
-38.14%
1-Day Range:
$0.96
$1.035
1-Week Range:
$0.955
$1.06
52-Week Range:
$0.7709
$1.67
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
Compare CRDL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
0.965 | 99.65M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Initiated | H.C. Wainwright | Buy |
| Jan-28-25 | Initiated | Rodman & Renshaw | Buy |
| Jun-26-24 | Initiated | ROTH MKM | Buy |
| Apr-22-24 | Initiated | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc Stock (CRDL) Latest News
Is Cardiol Therapeutics Inc. stock a dividend growth opportunityJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com
What is the fair value of Cardiol Therapeutics Inc. stock now2025 Market Overview & AI Forecast for Swing Trade Picks - newser.com
How Cardiol Therapeutics Inc. stock responds to policy changesWeekly Trend Report & Technical Entry and Exit Tips - newser.com
How Cardiol Therapeutics Inc. stock performs during Fed tightening cyclesTrade Analysis Summary & Real-Time Price Movement Reports - newser.com
Will Cardiol Therapeutics Inc. (CT9) stock recover faster than industry2025 Bull vs Bear & Consistent Return Investment Signals - newser.com
Is Cardiol Therapeutics Inc. (CT9) stock undervalued after correctionJuly 2025 Setups & Detailed Earnings Play Alerts - newser.com
Is Cardiol Therapeutics Inc. stock poised for growthQuarterly Growth Report & Verified Trade Idea Suggestions - newser.com
Historical volatility pattern of Cardiol Therapeutics Inc. visualized2025 Market WrapUp & Growth Focused Stock Reports - newser.com
How buyback programs support Cardiol Therapeutics Inc. (CT9) stockProfit Target & Free High Return Stock Watch Alerts - newser.com
Cardiol Therapeutics Inc. stock chart pattern explainedJuly 2025 Levels & Technical Buy Zone Confirmations - newser.com
Is Cardiol Therapeutics Inc. (CT9) stock undervalued at current priceWeekly Trade Recap & High Accuracy Investment Entry Signals - newser.com
Key metrics from Cardiol Therapeutics Inc.’s quarterly dataWeekly Trend Recap & High Conviction Buy Zone Picks - newser.com
How to build a custom watchlist for Cardiol Therapeutics Inc.Earnings Summary Report & Weekly High Potential Alerts - newser.com
Technical analysis overview for Cardiol Therapeutics Inc. stockJuly 2025 PostEarnings & Real-Time Chart Breakout Alerts - newser.com
Cardiol Therapeutics wins US patent protection for heart-disease drug platform - Indian Pharma Post
How Cardiol Therapeutics Inc. stock benefits from tech adoptionQuarterly Performance Summary & High Yield Equity Trading Tips - newser.com
What market sentiment indicators show for Cardiol Therapeutics Inc. (CT9) stockTrade Signal Summary & Fast Exit and Entry Trade Guides - newser.com
Where are the Opportunities in (CRDL) (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics Inc Stock (CRDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
6.17%
0.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):